Episode Details

In full disclosure, I am an investment advisor, and I practice what I preach. I have a method that I believe works, but as every compliance officer will remind you, past performance is no guarantee of future performance. At the end of this podcast, you will hear the full disclaimer, and I encourage you to listen carefully. But let me set the stage for where I am coming from. I favor large, well-capitalized companies over small speculative ones. I focus on megatrends, not on flipping stocks, day trading, or chasing the latest meme stock making headlines. I am old-fashioned, old-school, and unapologetically traditional in my approach.
My emphasis is on income over growth, because the people I work with are not 22-year-old TikTok traders. Nearly every one of my clients is over the age of fifty, many are fully retired, and the average client is probably somewhere between their mid-seventies and early eighties. That perspective matters. When you are living on the results of decades of hard work, your primary concern is cash flow, preservation, and stability—not wild speculation.
Because of that, I have no problem calling things the way I see them, even when it ruffles feathers. In this discussion, you are going to see that I am willing to take on the medical industry, the insurance industry, Big Pharma, and any other entrenched interest that profits at the expense of the public. If you are ready for a frank, fact-driven conversation about health, medicine, industry, and how these forces intersect with your financial life, buckle up—this is going to be a good one.
From a historical standpoint, there is no doubt that human longevity has been influenced more by evolving data, environmental awareness, and fundamental healthcare advances than by any modern medical breakthrough. Disease, famine, unsanitary conditions, and the lack of emergency medical care once shaped the very structure of society. The most profound improvements in public health came not from miracle cures, but from sanitation. Clean, running water, the recognition of basic nutritional needs, and the simple but powerful use of vitamins radically altered survival rates and extended lifespans across populations.
Consider polio as an example. Statistically, between 95 and 99 percent of those infected were asymptomatic—meaning they carried the virus but showed no outward signs of illness. They did not develop paralysis, fever, or the visible markers often associated with polio, yet they were counted in the broad measures of infection. This reality created a significant divide between perception and actual risk. The majority experienced no symptoms, but the minority who did suffer visible and lasting effects shaped the public’s understanding and fueled fear. The same dynamic resurfaced with COVID-19. A large percentage of individuals who tested positive were asymptomatic, experiencing no meaningful illness or impairment. Yet fear—driven by daily case counts, political decisions, and media amplification—overrode the statistical reality. Public policy was shaped less by the weight of evidence and more by the amplification of fear, much as it had been during the polio era.
Another dimension of the polio story is less frequently discussed: the role of vaccination itself in producing harm. Many individuals suffered adverse effects from early polio vaccination campaigns. In certain cases, recipients of the vaccine not only developed illness but contracted polio as a direct result of the vaccination process. This was most notably exposed in the Cutter Incident of 1955, when a batch of improperly inactivated vaccines led to thousands of cases of vaccine-induced polio. Some children were permanently paralyzed, and others died. When the numbers are compared, the sobering reality emerges: for a measurable period, the number of individuals harmed or infected by the vaccination process itself rivaled or even exceeded the number who would otherwise have been naturally inf